跳至主要内容
临床试验/CTRI/2016/04/006832
CTRI/2016/04/006832已完成1 期

Evaluation of clinical efficacy and safety of Bonton active granules in the management of osteoporosis

Vasu Research Centre VRC0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Osteopenic/osteoporotic patients of either sex whose BMD (t score) is equal to or less than 1 will be selected for the present study
  • Patients between the age group of 40 and 70 years and willing to give consent to participate in the study

排除标准

  • Patients whose age is below 40 and above 70 years
  • Patients whose BMD (t score) is above 1 will be excluded from the present study
  • Patients suffering from neoplasm of the bone will be excluded
  • Known cases of poorly controlled Hypertension or with uncontrolled Diabetes Mellitus or suffering from Thyrotoxicosis Hyper Parathyroidism Addisonâ??s disease Pagetâ??s disease Cushingâ??s SyndromeTuberculosis of the bone Osteomalacia chronic renal failure hepatic and cardiac failure will also be excluded from present clinical trial
  • Rheumatoid arthritis, Gouty arthritis and any long standing systemic disease will be excluded

研究者

发起方
Vasu Research Centre VRC

相似试验